This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gonzalez-Angulo AM et al. (2004) Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment. Cancer 101: 1760–1766
Auperin A et al. (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341: 476–484
O'Shaughnessy JA (2003) Chemotherapy-induced cognitive dysfunction: a clearer picture. Clin Breast Cancer 4 (Suppl 2): S89–S94
Ayers M et al. (2004) Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 22: 2284–2293
Acknowledgements
The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Glossary
- RTOG
-
Radiation Therapy Oncology Group
Rights and permissions
About this article
Cite this article
Rogers, L. What are the risk factors for brain metastasis in breast cancer patients?. Nat Rev Clin Oncol 2, 124–125 (2005). https://doi.org/10.1038/ncponc0103
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0103